Search the Newsreel

Cincinnati Financial Corp. stock underperforms Monday when compared to competitors

Shares of Cincinnati Financial Corp. (CINF) fell by 1.70% on Monday, closing at $173.86. This underperformance occurred during a generally negative trading session, with both the S&P 500 Index and the Dow Jones Industrial Average also experiencing slight declines. This marked the second consecutive …

Purple Innovation Reports Second Quarter 2026 Results

Purple Innovation reported its second-quarter 2026 results, showing a net revenue decrease of 6.5% to $98.3 million compared to the previous year, primarily due to lower wholesale revenue, though direct-to-consumer revenue increased. The company achieved a GAAP Net Loss of $3.2 million and an …

Royal Bank Of Canada Lowers Finning International (TSE:FTT) Price Target to C$129.00

Pinnacle West Capital Corp. stock underperforms Monday when compared to competitors

Pinnacle West Capital Corp. (PNW) shares dropped 1.78% on Monday, closing at $99.23, while the broader market indices, the S&P 500 and Dow Jones Industrial Average, experienced smaller declines. The company's stock is now 10.73% below its 52-week high of $111.16, reached on July …

Innio N.V. Investigated by the Portnoy Law Firm

The Portnoy Law Firm has launched an investigation into potential securities fraud involving Innio N.V. on behalf of its investors. This follows Innio's announcement of underperforming financial results for Q2 2026, including a net loss of $16.9 million and shrinking profit margins, which caused …

AIM Market Roundup: Strip Tinning, Thruvision, Devolver Digital

NHTSA Releases its Most Recent Installment of RV Recalls

The National Highway Traffic Safety Administration (NHTSA) has released its latest RV recall notices, affecting several manufacturers. Winnebago is recalling Ekko motorhomes for touchscreen issues that can unexpectedly activate generators, Brinkley RV is recalling Model I trailers due to improperly secured exterior ladders, and …

Sobi broadens portfolio through Innate Pharma partnership

Sobi and Innate Pharma have formed a strategic partnership for lacutamab, a drug candidate for cutaneous T-cell lymphoma (CTCL). Sobi will gain exclusive global commercialization rights if accelerated approval is granted and holds an option for full development responsibilities after positive Phase III results. …

Unlocking Onto Innovation (ONTO) International Revenues: Trends, Surprises, and Prospects

Have you looked into how Onto Innovation (ONTO) performed internationally during the quarter ending June 2026? Considering the widespread global presence of this maker of semiconductor manufacturing equipment, examining the trends in international revenues is essential for assessing its financial resilience and prospects for …

Rigaku Receives $720M Minority Investment From Onto Innovation

Rigaku Holdings Corporation, a Japanese provider of advanced X-ray technologies for semiconductor manufacturing process control, secured a $720M minority equity investment from Onto Innovation Inc. The funds will be used to deepen their strategic collaboration with Onto Innovation and accelerate the development of advanced …

Innovate Corp. (NYSE: VATE) files $100M shelf as asset sales reshape business

Innovate Corp. (NYSE: VATE) has filed a shelf registration statement to offer up to $100 million in mixed securities, including common and preferred stock, as it reshapes its business through significant asset sales. The company plans to sell its DBM Global (Infrastructure) and merge …

Form 8K Innovate Corp For: 10 August By Investing.com

This article announces the filing of a Form 8K by Innovate Corp on August 10th. The brief piece primarily serves as a notice of the regulatory filing and includes market data and related news. It appears to be an automated or very short report …

Despite Fast-paced Momentum, Summit Hotel Properties (INN) Is Still a Bargain Stock

Summit Hotel Properties (INN) is identified as a bargain stock with fast-paced momentum, according to Zacks Equity Research. The article highlights its recent price momentum, strong beta of 1.26, and a favorable Zacks Rank #2 (Buy) due to upward earnings estimate revisions. Despite these …

INNOVATE Plans Debt Reduction Using DBM Global Sale Proceeds

Onto Innovation Completes Strategic Investment in Rigaku Holdings Corporation

Investment deepens strategic collaboration to advance next-generation X-ray-based process control solutions for semiconductor manufacturing WILMINGTON, Mass., August 10, 2026--(BUSINESS WIRE)--Onto Innovation Inc. (NYSE: ONTO) today announced the successful closing of its previously announced acquisition of a 27% minority equity stake in Rigaku Holdings Corporation …

Onto Innovation Takes 27% Rigaku Stake to Advance X-Ray Tools

Bannari Amman Spinning Mills Ltd Reports Earnings Results for the First Quarter Ended June 30, 2026

Sobi pens $580M deal for Innate’s cancer drug before ph. 3 push

Sobi has acquired global commercialization rights to Innate Pharma’s cancer drug, lacutamab, for $75 million upfront, with potential milestones up to $580 million. The deal will fund the phase 3 Tellomak-3 study for cutaneous T-cell lymphoma (CTCL), particularly Sézary syndrome, aiming for an accelerated …

Bannari Amman Spinning Mills consolidated net profit rises 200.22% in the June 2026 quarter

Why InnoCare Pharma (SEHK:9969) Is Up 12.9% After Dual Breakthrough Therapy Wins in Cancer and Autoimmune Disease - And What's Next

Sobi adds rare lymphoma drug with $580m Innate tie-up

Sobi has entered a partnership with Innate Pharma, paying $75 million upfront and up to $505 million in milestones, for the rare lymphoma drug lacutamab. This deal allows Innate to initiate a phase 3 trial for lacutamab in Sézary syndrome, a rare form of …

Strip Tinning stock surges on GBP3 million grant win

Strip Tinning Share News (STG)

Innate Pharma Jumps After Sobi Deal To Advance Lacutamab Into Phase 3; Appoints Markus Jensen As CMO

(RTTNews) - Shares of Innate Pharma S.A. (IPHA), a clinical-stage company, surge over 25% after the company announced a strategic partnership with Swedish Orphan Biovitrum AB (SOBI.ST) to enable initiation of the TELLOMAK-3 confirmatory Phase 3 study of Lacutamab, an investigational anti-KIR3DL2 antibody in …

Ashington Innovation agrees GBP160 million reverse takeover of WMG

Ashington Innovation (ASHI) Announces £160 Million Acquisition of Singapore-Based World Metal Group and Trading Suspension

Innate Pharma (NASDAQ: IPHA) secures Sobi deal, $75M upfront and Phase 3 push

Innate Pharma Names Markus Jensen Chief Medical Officer; Phase 3 Planned

Innate Pharma Jumps as Sobi Deal Boosts Secured Financing for Advancing Rare Skin Cancer Therapy

Innate Pharma and Sobi have formed a strategic alliance, with Sobi providing an initial $75 million payment and up to $40 million in short-term developmental milestones, to advance a Phase 3 clinical trial for lacutamab, a rare skin cancer therapy. This collaboration aims to …

China Innovation Investment Sets Board Meeting to Review Interim Results and Dividend

Innovative Eyewear Inc SEC Filing (Aug 10, 2026)

Innovative Eyewear Inc (NASDAQ: LUCY) filed a Notice of Effectiveness with the SEC on August 10, 2026, for its S-1 registration form, which became effective on August 7, 2026, at 5:00 P.M. The filing impact and sentiment are noted as neutral. The article also …

INNODATA INC SEC Filing (Aug 10, 2026)

This article reports on an SEC filing by INNODATA INC (INOD) on August 10, 2026, classified as an EFFECT filing with a neutral impact and sentiment. The filing pertains to a Notice of Effectiveness with an effective date of August 7, 2026. The article …

Transcript : Nitin Spinners Limited, Q1 2027 Earnings Call, Aug 10, 2026

Purple Innovation (NASDAQ:PRPL): What Could Today’s Update Reveal About Sleep-Product Demand And Brand Execution?

Purple Innovation (NASDAQ:PRPL) is scheduled to release a quarterly update today, which is expected to provide insights into sleep-product demand and the company's brand execution. The update will clarify the quality of current demand and Purple Innovation's ability to translate operational priorities into sustained …

Assenagon Asset Management S.A. Sells 813,931 Shares of Pinnacle West Capital Corporation $PNW

Assenagon Asset Management S.A. significantly reduced its stake in Pinnacle West Capital Corporation by 81.7%, selling 813,931 shares and retaining 182,222 shares valued at approximately $19.5 million. Despite institutional investors owning a large portion of the company, analysts maintain a cautious "Hold" rating with …

Sobi, Innate Join To Conduct TELLOMAK-3 Phase 3 Confirmatory Trial In Cutaneous T-cell Lymphoma

(RTTNews) - Swedish Orphan Biovitrum AB (SOBI.ST) and Innate Pharma (IPHA, IPH, IPH.PA) have entered a strategic partnership to enable initiation of the TELLOMAK-3 confirmatory Phase 3 study in cutaneous T cell lymphoma, a key step toward filing for accelerated approval of lacutamab in …